BioPhy launches AI platform to accelerate drug development with $4.5M investment led by Chelsea Clinton’s VC firm

Investors in BioPhy include Chelsea Clinton and Caroline Kassie's Metrodora Ventures along with Jeff Marrazzo, co-founder and former CEO of Spark Therapeutics.

Previous Accounting giants to join forces as Mazars USA agrees to create network with Forvis
Next How to succeed in real estate? Don't be a perfectionist, says Liz Dunn